New Clinical Trials for Migraine Headaches

Enroll in a Clinical Trial for Migraine HeadachesMigraine headaches have long been discussed throughout history with evidence of them being documented as far back as 9,000 years ago. Today about 10% of the population is affected by migraines. Women are three times as likely to be sufferers than men. Because the cause is still almost completely unknown there is great a need for migraine headache clinical studies. If you suffer from migraine headaches take comfort in the fact that there are always new migraine headache clinical trials.

What are Migraine Headaches?

Migraine headaches are defined as severe headaches often accompanied by nausea and even vomiting. Migraine headaches are characterized by pulsating, throbbing pain in the head. A migraine can last anywhere from two hours up to seventy two hours. Migraine sufferers sometimes experience what is known as an aura – a combination of visual and sensory indicators that a migraine is about to occur.

During the migraine itself they are often overly sensitive to light, noise and movement. The cause of migraines is unknown; however, there seems to be agreement that they are most likely caused by a combination of neural (affects the nerves of the brain) and vascular (affects the blood vessels) factors.

Migraine Headaches Treatments

Migraines treatments include prevention when possible. Some sufferers know what will cause a headache and they avoid those things. Triggers can include bright light or loud noises. Those suffering from migraine headaches often just want a dark, quiet room to rest in until the episode passes.

Medications used for treating migraines include analgesics such as ibuprofen, Naproxen and aspirin. Caffeine can also help in that it slows vomiting and allows drugs to be absorbed in the stomach. Other drugs used in the treating migraines include triptans, ergotamine and steroids.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
797 Migraine Headaches
clinical trials

Neurology Clinical Trial
Migraine Headaches Clinical Trial
Status: Upcoming
mi
from
DeLand, FL
Click here to add this to my saved trials
Forward Head Posture With Associated Episodic Headache Disorder Clinical Trial
Safety and Efficacy Study of Botox in the Treatment of Forward Head Posture With Associated Episodic Headache Disorder
Status: Enrolling, Phase II, III
Updated: 5/6/2011
mi
from
Oceanside, CA
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
mi
from
Fairfield, CT
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Akron, OH
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Norfolk, VA
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Amherst, NY
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Aurora, CO
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
Dallas, TX
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
New York, NY
Click here to add this to my saved trials
Neurology Clinical Trial
The Childhood and Adolescent Migraine Prevention Study
Status: Enrolling, Phase III
Updated: 11/10/2014
mi
from
San Francisco, CA
Click here to add this to my saved trials
Migraine Clinical Trial
Occipital Nerve Stimulation in the Treatment of Migraine
Status: Enrolling
Updated: 6/1/2013
mi
from
Newington, NH
Click here to add this to my saved trials
Headache Clinical Trial
eNeura SpringTMS Post-Market Observational US Study of Migraine
Status: Enrolling
Updated: 10/9/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Headache Clinical Trial
eNeura SpringTMS Post-Market Observational US Study of Migraine
Status: Enrolling
Updated: 10/9/2015
mi
from
New York, NY
Click here to add this to my saved trials
Neurology Clinical Trial
Rizatriptan for Episodic Dizziness in Vestibular Migraine
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Clinical Decision Rule for Pediatric Intracranial Pathology
Status: Enrolling
Updated: 4/13/2016
mi
from
St. Paul, MN
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Migraine Headache Clinical Trial
Study of Low-level Laser Therapy in the Acute Treatment of Migraine
Status: Enrolling, Phase II
Updated: 12/1/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Episodic Cluster Headache Clinical Trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Episodic Cluster Headache Clinical Trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Episodic Cluster Headache Clinical Trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
mi
from
Amherst, NY
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
mi
from
Louisville, KY
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology Clinical Trial
CBT Depression Intervention for Co-Occurring Chronic Headache
Status: Enrolling
Updated: 3/27/2017
mi
from
Detroit, MI
Click here to add this to my saved trials
Migraine Clinical Trial
Migraine and CVD Risk in Women
Status: Enrolling
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cluster Headache Clinical Trial
A Study to Explore the Long-Term Safety of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Cluster Headache Clinical Trial
A Study to Explore the Long-Term Safety of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Cluster Headache Clinical Trial
A Study to Explore the Long-Term Safety of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Migraines Clinical Trial
Pain Processing in Adults With Migraines
Status: Enrolling
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness
Status: Enrolling
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Neurology, Other Clinical Trial
The Will Erwin Headache Research Center - Cluster Headache Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Amherst, NY
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fairfield, CT
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Plymouth, MN
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fairfield, CT
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Long Beach, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
Status: Enrolling
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Amherst, NY
Click here to add this to my saved trials
Neurology Clinical Trial
Understanding the Pathophysiology of Migraine Pain
Status: Enrolling
Updated: 4/21/2018
mi
from
Bronx, NY
Click here to add this to my saved trials
Neurology Clinical Trial
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
Status: Enrolling
Updated: 12/31/1969
mi
from
La Jolla, CA
Click here to add this to my saved trials
Musculoskeletal, Neurology, Psychiatry / Psychology, Rheumatology, Orthopedics / Podiatry Clinical Trial
Offset Analgesia as a Measure of Central Sensitization in Children
Status: Enrolling
Updated: 12/31/1969
mi
from
Waltham, MA
Click here to add this to my saved trials
Post-Dural Puncture Headache Clinical Trial
RCT of SPG Blocks for Post-dural Headache
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Migraine Clinical Trial
Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Bronx, NY
Click here to add this to my saved trials
Migraine Clinical Trial
CHOCOlate MeLatonin for AdolescenT MigrainE
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Stanford, CA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Lampasas, TX
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Raleigh, NC
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Boulder, CO
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Great Neck, NY
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Newburgh, IN
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Newton, KS
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Richmond, VA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tulsa, OK
Click here to add this to my saved trials
Post-Traumatic Headache Chronic Without Intractable Headache Clinical Trial
Nutrition for Post-Traumatic Headache
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bethesda, MD
Click here to add this to my saved trials
Post-Traumatic Headache Chronic Without Intractable Headache Clinical Trial
Nutrition for Post-Traumatic Headache
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Belvoir, VA
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fresno, CA
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lebanon, NH
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Little Rock, AR
Click here to add this to my saved trials
1 2 3 4 5 6 7 8